Feed / AMRX

Amneal Pharmaceuticals, Inc.

AMRX

Healthcare · 17.93 +0.8% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Amneal Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.

What changed
  • Revenue increased 9.9% versus the comparable filing period.
Company+0.8% todayVolume comparison unavailable
Market group0 of 1 activeSpecialty Pharmaceuticals · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Affordable Medicines margin rose as recently launched products and higher sales volumes improved mix, partly offset by plant, freight, and inventory-obsolescence costs.
  • Interest expense decreased $3.6M period-over-period due to lower rates and lower variable-rate debt balances; a $3.5M refinancing loss was recorded in Q1 2026.

Invalidation: The isolated read changes if AMRX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind AMRX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

TAKTakeda Pharmaceutical Company LimitedpartnerAug 7, 2025 ▾

“On February 28, 2024, Takeda Pharmaceuticals U.S.A., Inc.”

ALKSAlkermes plcsupplierFeb 27, 2026 ▾

“Alkermes Plc Rondo Partners LLC purchases inventory from Alkermes Plc for resale.”

Depended on by

SPRYARS Pharmaceuticals, Inc.competitorMay 15, 2026 ▾

“Additionally, the development of new treatment methods for the diseases we are targeting could render our current or future product candidates non-competitive or obsolete.”

Filing peers

OGNBIIBRARE

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 14 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

AMRX is currently a Leader in the organic co-movement group Specialty Pharmaceuticals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for AMRX; it is not active in the latest market snapshot.